calendar
4,970 catalysts · 4,970 phase readout · 2,346 8k filing · 287 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion
4,970 catalysts · 4,970 phase readout · 2,346 8k filing · 287 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion
no tagged catalysts yet
Sponsor: REGENXBIO Inc.. Phase: . Conditions: Duchenne Muscular Dystrophy
Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Anal Incontinence
Sponsor: University Hospital, Basel, Switzerland. Phase: PHASE2. Conditions: Palliative Care, Pain, Anxiety, Depression, Demoralization, Psychological Distress, Quality of Life, Caregiver Burden, Fear of Death, Existential Distress
Sponsor: Cara J. Hamann. Phase: NA. Conditions: Bicycling, Knowledge, Adolescent, Self Efficacy, Education, Attitudes, Practice, Safety, Behavior
Sponsor: Cedars-Sinai Medical Center. Phase: . Conditions: Breast Cancer, Breast Cancer Survivors
Sponsor: Mansoura University. Phase: NA. Conditions: Tooth Extraction
Sponsor: Sohag University. Phase: NA. Conditions: Infertile Women With Pelvic Adhesions
Sponsor: University Hospital, Angers. Phase: . Conditions: Thoraco-brachial Outlet Syndrome, ADAP-shoulder Scale, PETRA
Sponsor: Spinogenix. Phase: PHASE2. Conditions: Amyotrophic Lateral Sclerosis
Sponsor: Istituto Ortopedico Rizzoli. Phase: . Conditions: Multiple Osteochondroma
Sponsor: Methodist Health System. Phase: . Conditions: Gastro-Intestinal Disorder
Sponsor: University Health Network, Toronto. Phase: . Conditions: Respiratory Insufficiency, Diaphragm Injury, Mechanical Ventilation Complication
Sponsor: Tanta University. Phase: NA. Conditions: Ppm, Cardiomyopathy
Sponsor: La Jolla Institute for Immunology. Phase: PHASE4. Conditions: Influenza A
Sponsor: University of California, San Diego. Phase: NA. Conditions: Suicidal Ideation
Sponsor: Yongquan Shi. Phase: PHASE2. Conditions: Radiation Enteritis
Sponsor: Shanghai Junshi Bioscience Co., Ltd.. Phase: PHASE2. Conditions: Advanced Esophageal Squamous Cell Carcinoma
Sponsor: University Hospital Bispebjerg and Frederiksberg. Phase: NA. Conditions: Auditory Hallucinations, Schizophrenia
Sponsor: Tunghai University. Phase: NA. Conditions: Aging, Sleep Quality, Physical Performance
Sponsor: University of Southampton. Phase: PHASE2. Conditions: Colorectal Cancer
Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Case Report Form, Declaration Bias, Health Insurance Database
Sponsor: University of Paris 5 - Rene Descartes. Phase: . Conditions: Pulmonary Disease, Chronic Obstructive
Sponsor: Sedana Medical. Phase: PHASE3. Conditions: Sedation
Sponsor: NYU Langone Health. Phase: PHASE4. Conditions: Metastatic Melanoma, Advanced Melanoma
Sponsor: Centre Jean Perrin. Phase: NA. Conditions: Locally Advanced Head and Neck Carcinoma
Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: PHASE2. Conditions: Bile Duct Cancer
Sponsor: Chang Gung Memorial Hospital. Phase: PHASE2. Conditions: Hepatocellular Carcinoma Non-resectable
Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Intubation, Intratracheal, Airway Management, Video Laryngoscope, Cost Effectiveness
Sponsor: Danderyd Hospital. Phase: . Conditions: Coronary Artery Disease, Arterial Stiffness, Blood Pressure, AORTIC VALVE DISEASES, Mitral Valve Stenosis and/or Insufficiency, Heart Failure, Pulmonary Disease, Chronic Obstructive (COPD), Steatohepatitis, Inflammation Biomarkers, Lipid Profile, Oral Microbiota, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Associated-dysfunction Steatohepatitis (MASH)
Sponsor: University of Regina. Phase: PHASE1. Conditions: Healthy
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Amyotrophic Lateral Sclerosis
Sponsor: Hospital Clinic of Barcelona. Phase: NA. Conditions: Prostate Cancer, Radical Prostatectomy
Sponsor: Fondazione Don Carlo Gnocchi ETS. Phase: . Conditions: Lower Limb Amputation, Slip Perturbations, Fall Risk
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: . Conditions: Patients for Whom an Angiomammogram Examination is Requested Whether Its Indication
Sponsor: Pfizer. Phase: PHASE2. Conditions: Elranatamab, Myeloma, Multiple Myeloma, Relapsed Multiple Myeloma, Refractory Multiple Myeloma, PF-06863135, BCMA, Bispecific, Bispecific Antibody, BCMA-CD3 Bispecific, MagnetisMM-8
Sponsor: SparingVision. Phase: PHASE1. Conditions: Retinitis Pigmentosa
Sponsor: Duke University. Phase: NA. Conditions: Infections
Sponsor: Hôpital NOVO. Phase: . Conditions: Plastic Surgery
Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Status Asthmaticus
Sponsor: University Hospital, Lille. Phase: . Conditions: Chronic Rhinosinusitis With Nasal Polyps
Sponsor: Boston Scientific Corporation. Phase: . Conditions: Chronic Pain
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: NA. Conditions: Brain Cancer
Sponsor: Murdoch Childrens Research Institute. Phase: NA. Conditions: Food Allergy, Food Allergy in Infants
Sponsor: Alexion Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Neuromyelitis Optica Spectrum Disorder
Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Chronic Pain, Opioid Use, Cannabis
Sponsor: Azienda Ulss 2 Marca Trevigiana. Phase: . Conditions: Asthma, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Sponsor: Sun Yat-sen University. Phase: PHASE1. Conditions: Relapsed or Refractory Peripheral T Cell Lymphoma, NKTCL
Sponsor: COVID-19 Prevention Network. Phase: . Conditions: Tuberculosis
Sponsor: Synbiotic Health. Phase: NA. Conditions: Healthy Aging, Anti Aging
Sponsor: Mesoblast, Inc.. Phase: PHASE2. Conditions: Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent, Juvenile Diabetes